Anti-tumor necrosis factor α: originators <i>versus</i> biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

• Main Authors: C. Gioia (Author), A. Picchianti Diamanti (Author), R. Perricone (Author), M.S. Chimenti (Author), A. Afeltra (Author), L. Navarini (Author), A. Migliore (Author), U. Massafra (Author), V. Bruzzese (Author), P. Scolieri (Author), C. Meschini (Author), M. Paroli (Author), R. Caccavale (Author), P. Scapato (Author), R. Scrivo (Author), F. Conti (Author), B. Laganà (Author), M. Di Franco (Author)
• Format: Book
• Published: PAGEPress Publications, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective. To compare etanercept and adalimumab biosimilars (SB4 and ABP501) and respective bioriginators in terms of safety and efficacy in a real-life contest. Methods. We consequently enrolled patients affected by rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, treated with...